The role of carbon dioxide angiography in reducing contrast-induced nephropathy in diabetic foot patients undergoing endovascular treatment
Die Rolle der Kohlendioxid-Angiographie zur Reduktion einer kontrastmittelinduzierten Nephropathie bei Patient:innen mit diabetischem Fuß unter endovaskulärer Behandlung
Turkish Journal of Medical Sciences · 15.08.2025 · 55 (4) · 877-886
DOI: 10.55730/1300-0144.6040 ↗Auf einen Blick
Bei 272 Patient:innen mit diabetischem Fuß war die CO2-Angiographie mit weniger Kontrastmittel und seltenerer kontrastmittelinduzierter Nephropathie verbunden. Die technische Erfolgsrate war vergleichbar.
Fragestellung
Reduziert CO2-Angiographie bei Patient:innen mit diabetischem Fuß unter endovaskulärer Revaskularisation den Kontrastmittelbedarf und das Risiko einer kontrastmittelinduzierten Nephropathie?
Methode
272 Patient:innen mit infrainguinaler chronischer pAVK; 64 mit CO2-Angiographie, 208 nur mit Kontrastmittel. Erfasst wurden CIN, Kontrastmenge, technischer Erfolg und Komplikationen.
Ergebnisse
Kontrastmittelmenge: 24,3 ± 13,3 cc vs. 89,4 ± 24,8 cc (p < 0,001). CIN: 6,2 % vs. 17,7 % (p = 0,024). Bei CKD Stadium 3–5: 6,2 % vs. 38,2 %; OR 0,027 (95 %-KI 0,005–0,133).
Schlussfolgerung der Autor:innen
CO2-Angiographie könnte in dieser Population das Risiko einer CIN deutlich verringern. Die Autoren sehen weitere multizentrische prospektive Studien als nötig an.
Kernaussagen
- Weniger Kontrastmittel mit CO2-Angiographie
- Niedrigere CIN-Rate unter CO2
- Technischer Erfolg und Komplikationen ähnlich
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Fachartikel in der Zeitschrift Turkish Journal of Medical Sciences, online erschienen am 15.08.2025. Verfasst von Sadık Ahmet Uyanik und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Etlik City Hospital, Ankara, Turkiye. Hauptthemen laut MEDLINE: Contrast Media, Carbon Dioxide, Endovascular Procedures, Diabetic Foot. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Diabetisches Fußsyndrom
Abstract (Originalsprache)
Background/aim: This study investigates the role of carbon dioxide (CO2) angiography, delivered with an automated CO2 delivery system, in decreasing the amount of iodinated contrast and preventing contrast-induced nephropathy (CIN) in diabetic foot patients who underwent endovascular revascularization. Materials and methods: A total of 272 diabetic foot patients who underwent endovascular treatment for infrainguinal chronic peripheral arterial disease (PAD) were included in the study. Of these, 64 patients underwent endovascular intervention using CO2 angiography (study group), while 208 patients underwent endovascular intervention using only contrast media (control group). The rates of CIN and the amount of contrast used during interventions were recorded alongside secondary outcomes, including technical success, complication rates, and complications related to CO2 usage.
Results
The mean contrast volume used in the CO2 group was significantly lower than in the control group (24.3 ± 13.3 cc vs 89.4 ± 24.8 cc; p < 0.001). CIN was detected in 41 patients. The incidence of CIN was 17.7% in the control group, while it was significantly lower in the CO2 group at 6.2% (p = 0.024). In a subgroup of patients with chronic kidney disease stage 3–5, CIN incidence remained significantly lower in the CO2 group (6.2% vs 38.2%, p < 0.001), and multivariate analysis identified CO2 use as an independent protective factor (OR: 0.027, 95% CI: 0.005–0.133, p < 0.001). Technical success rates were comparable between the groups (93.7% vs 93.2%; p = 0.892). Pain after CO2 injection was recorded in 11 patients, and no other adverse effect due to CO2 usage was observed. There were no major complications, and only minor complications occurred (8%).
Conclusion
CO2 angiography may play a crucial role in minimizing the risk of CIN in this specific population, who are more vulnerable to this complication and its associated morbidity and mortality. Further multicenter prospective studies are needed to better define the role of CO2 angiography in high-risk patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiology, Etlik City Hospital, Ankara, Turkiye.
- Department of Radiology, Ankara Training and Research Hospital, University of Health Sciences, Ankara, Turkiye.
- Department of General Surgery, Etlik City Hospital, Ankara, Turkiye.
ORCID-Profile: Sadık Ahmet Uyanik, Erdem Birgi, Saffet Öztürk, Umut Asfuroğlu, Erdi Tangobay, Hikmet Erhan Güven
Zitieren
APA
Uyanik, S. A., Birgi, E., Öztürk, S., Asfuroğlu, U., Tangobay, E., & Güven, H. E. (2025). The role of carbon dioxide angiography in reducing contrast-induced nephropathy in diabetic foot patients undergoing endovascular treatment. Turkish Journal of Medical Sciences, 55(4), 877-886. https://doi.org/10.55730/1300-0144.6040
Vancouver
Uyanik SA, Birgi E, Öztürk S, Asfuroğlu U, Tangobay E, Güven HE. The role of carbon dioxide angiography in reducing contrast-induced nephropathy in diabetic foot patients undergoing endovascular treatment. Turkish Journal of Medical Sciences. 2025;55(4):877-886. doi:10.55730/1300-0144.6040
BibTeX
@article{Uyanik2025,
author = {Uyanik, Sadık Ahmet and Birgi, Erdem and Öztürk, Saffet and Asfuroğlu, Umut and Tangobay, Erdi and Güven, Hikmet Erhan},
title = {The role of carbon dioxide angiography in reducing contrast-induced nephropathy in diabetic foot patients undergoing endovascular treatment},
journal = {Turkish Journal of Medical Sciences},
year = {2025},
volume = {55},
number = {4},
pages = {877--886},
doi = {10.55730/1300-0144.6040}
}
EUVIMED